- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
IFI6 Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP12965a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP12965a-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
IFI6 Antibody (N-term) - Product info | |
| Application | WB
|
| Primary Accession | P09912 |
| Other Accession | NP_002029.3 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 12927 Da |
IFI6 Antibody (N-term) - Additional info | |
| Gene ID 2537 | |
| Other Names IFI6; G1P3; Interferon alpha-inducible protein 6; Interferon-induced protein 6-16 | |
| Target/Specificity This IFI6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 4-34 amino acids from the N-terminal region of human IFI6. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions IFI6 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
IFI6 Antibody (N-term) - Protein Information | |
| Name IFI6 | |
| Synonyms G1P3 | |
| Cellular Location Membrane; Multi-pass membrane protein (Potential) | |
IFI6 Antibody (N-term) - Related products
AP12965a: IFI6 Antibody (N-term)
DC03138: Human IFI6 cDNA Clone
IFI6 Antibody (N-term) - Application data
-
IFI6 Antibody (N-term) (Cat. #AP12965a) western blot analysis in MDA-MB453,CEM cell line lysates (35ug/lane).This demonstrates the IFI6 antibody detected the IFI6 protein (arrow).
IFI6 Antibody (N-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene was first identified as one of the many genes induced by interferon. The encoded protein may play a critical role in the regulation of apoptosis. A minisatellite that consists of 26 repeats of a 12 nucleotide repeating element resembling the mammalian splice donor consensus sequence begins near the end of the second exon. Alternatively spliced transcript variants that encode different isoforms by using the two downstream repeat units as splice donor sites have been described.
REFERENCES
Davila, S., et al. Genes Immun. 11(3):232-238(2010) Szegedi, K., et al. Exp. Dermatol. 19(3):269-278(2010) Johnatty, S.E., et al. PLoS Genet. 6 (7), E1001016 (2010) : Zhao, D., et al. Virol. J. 5, 114 (2008) : Cheriyath, V., et al. J. Clin. Invest. 117(10):3107-3117(2007)
